Cargando…
Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies
Thrombocytopenia (platelet count <150 × 10(9)/L) often complicates chronic liver disease, impeding optimal management of these patients. The prevalence of this manifestation ranges from 6 % among non-cirrhotic patients with chronic liver disease to 70 % among patients with liver cirrhosis. It has...
Autores principales: | Maan, Raoel, de Knegt, Robert J., Veldt, Bart J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642582/ https://www.ncbi.nlm.nih.gov/pubmed/26501978 http://dx.doi.org/10.1007/s40265-015-0480-0 |
Ejemplares similares
-
Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease
por: Maan, Raoel, et al.
Publicado: (2016) -
Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis
por: Ng, Derry Minyao, et al.
Publicado: (2021) -
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
por: Kolaric, Tea Omanovic, et al.
Publicado: (2023) -
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
por: Maan, Raoel, et al.
Publicado: (2015) -
Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
por: Nakajima, Kei
Publicado: (2012)